Call Now: +1 858 800 3101 Email: info@innopep.com
Shopping Cart
0 Item(s) - $0.00
Your shopping cart is empty!
LL13 - 37
| Overview | |
|---|---|
| Description | This peptide is an active segment of LL-37, a peptide derived from the C-terminal domain of human cathelicidin antimicrobial peptide. It has been reported that the LL13-37 peptide exhibits reversal effect on ABCG2-mediated multidrug resistance in cancer cell lines. |
| Sequence | IGKEFKRIVQRIKDFLRNLVPRTES |
| Sequence (3 Letter) | H-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH |
| Molecular Weight | 3043.6 |
| Properties | |
| Purity | > 95% By HPLC |
| Storage | Store at -20 °C, cap vial tightly at all times. |
Dürr, UHN. et al. Biochim Biophys Acta 1758, 1408 (2006); To, KK. et al. Peptides 40,13 (2013).
About InnoPep
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.